Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion
NCT00232219Phase 4Completed
- Sponsor
- Melbourne Health
- Start
- Jan 2003
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of fish oil concentrate in Atrial fibrillation (AFib) (2 arms), sponsored by Melbourne Health. Primary endpoint: Recurrence of atrial fibrillation followed cardioversion at 1 year. Started Jan 2003; status: completed.
02
Drugs
fish oil concentrate
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00232219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00232219.